Springer Nature
Browse
12916_2018_1023_MOESM1_ESM.pdf (145.91 kB)

Additional file 1: of Comparison of treatment effect sizes from pivotal and postapproval trials of novel therapeutics approved by the FDA based on surrogate markers of disease: a meta-epidemiological study

Download (145.91 kB)
journal contribution
posted on 2018-03-21, 05:00 authored by Joshua Wallach, Oriana Ciani, Alison Pease, Gregg S. Gonsalves, Harlan Krumholz, Rod Taylor, Joseph Ross
Study protocol. (PDF 145 kb)

Funding

Laura and John Arnold Foundation

History

Usage metrics

    BMC Medicine

    Categories

    Keywords

    Surrogate markersOutcomesLifecycle evaluationRegulationU.S. Food and Drug Administration (FDA)

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC